Mr. Nathaniel Methot, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 18880 Cherry Valley Blvd, Tuolumne, CA 95379 Phone: 209-928-5400 |
Seth Holm, NURSE PRACTITIONER Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 20615 Ponderosa Way, Tuolumne, CA 95379 Phone: 209-928-3174 |
Mr. Robert Baker Hoffman, DC, RN, FNP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 18880 Cherry Valley Blvd, Tuolumne, CA 95379 Phone: 209-928-5400 Fax: 209-928-5412 |
Rebecca Ann Vierra-brick, FNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 18880 Cherry Valley Blvd, Tuolumne, CA 95379 Phone: 209-928-5400 |
Lorie D Weldon, M.S.N., F.N.P.-C. Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 18880 Cherry Valley Blvd, Tuolumne, CA 95379 Phone: 209-928-5400 |
Ms. Jane Louise Vanderlaag, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 18880 Cherry Valley Blvd, Tuolumne, CA 95379 Phone: 209-928-5400 Fax: 209-928-5412 |
News Archive
The National Institutes for Health has awarded Dr. Christian Grov and his colleagues $2.4 Million to launch a 2-year nationwide HIV prevention study of gay and bisexual men.
PhotoMedex, Inc. a leading provider of advanced dermatology, clinical skincare and medical laser products, is hosting a free seminar in Indianapolis, IN on November 17, 2009.
WellCare Health Plans, Inc. announced today that it has been awarded a Full Health Plan Accreditation for its HealthEase of Florida and WellCare of Florida subsidiaries by URAC, a Washington, DC-based health care accrediting organization that establishes quality standards for the health care industry. URAC's Health Plan Accreditation standards include key quality benchmarks for network management, provider credentialing, utilization management, quality management and improvement and consumer protection.
Flamel Technologies announced today that it has entered into a license agreement with a leading specialty pharmaceutical company for development and commercialization of two molecules for pain indications.
› Verified 5 days ago